During the past decade, Qilu hospital of Shandong University conducted 335 clinical trials. In the 10-year time frame, 335 clinical trials started and 13 clinical trials were completed, i.e. on average, 3.9% percent of trials that started reached the finish line to date. In the past 5 years, 205 clinical trials started and 7 clinical trials were completed. i.e. 3.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Qilu hospital of Shandong University" #1 sponsor was "Shandong University" with 103 trials, followed by "Qilu Hospital of Shandong University" with 71 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 14 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 8 trials sponsored and "BeiGene" with 8 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 129 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Qilu hospital of Shandong University" #1 collaborator was "Qilu Hospital of Shandong University" with 28 trials as a collaborator, "Shandong Provincial Hospital" with 22 trials as a collaborator, "Tongji Hospital" with 11 trials as a collaborator, "West China Hospital" with 11 trials as a collaborator and "Henan Provincial People's Hospital" with 10 trials as a collaborator. Other collaborators include 857 different institutions and companies that were collaborators in the rest 478 trials.

According to Clinical.Site data, the most researched conditions in "Qilu hospital of Shandong University" are "Immune Thrombocytopenia" (27 trials), "Helicobacter Pylori Infection" (20 trials), "Ovarian Cancer" (8 trials), "Colorectal Cancer" (6 trials) and "Gastric Cancer" (6 trials). Many other conditions were trialed in "Qilu hospital of Shandong University" in a lesser frequency.

Most popular intervention types in "Qilu hospital of Shandong University" are "Drug" (247 trials), "Other" (36 trials), "Device" (35 trials), "Procedure" (24 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Dexamethasone" (16 trials), "Paclitaxel" (8 trials), "Anlotinib" (7 trials) and "Prednisone" (6 trials). Other intervention names were less common.

The vast majority of trials in "Qilu hospital of Shandong University" are 345 trials for "All" genders, 40 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 187 active trials in "Qilu hospital of Shandong University". 25 are not yet recruiting, 124 are recruiting, 32 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 94 completed trials in Qilu hospital of Shandong University, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Qilu hospital of Shandong University, 26 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 51 trials, and there were also 73 trials that are defined as “Not Applicable".

Qilu hospital of Shandong University has several departments that took part in Clinical trials: "Department of Hematology, Provincial Hospital Affiliated to Shandong University" - 11 trials, "Department of Gastroenterology, Qilu Hospital, Shandong University" - 84 trials, "Endoscopic unit of Qilu Hospital Shandong University" - 3 trials, "Department of Gastrology, QiLu Hospital, Shandong University" - 2 trials